Cargando…
The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
by the American Academy of Dermatology, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235584/ https://www.ncbi.nlm.nih.gov/pubmed/32416207 http://dx.doi.org/10.1016/j.jaad.2020.05.035 |
| _version_ | 1783535988948074496 |
|---|---|
| author | Wan, Marilyn T. Shin, Daniel B. Winthrop, Kevin L. Gelfand, Joel M. |
| author_facet | Wan, Marilyn T. Shin, Daniel B. Winthrop, Kevin L. Gelfand, Joel M. |
| author_sort | Wan, Marilyn T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7235584 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | by the American Academy of Dermatology, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72355842020-05-19 The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic Wan, Marilyn T. Shin, Daniel B. Winthrop, Kevin L. Gelfand, Joel M. J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2020-08 2020-05-19 /pmc/articles/PMC7235584/ /pubmed/32416207 http://dx.doi.org/10.1016/j.jaad.2020.05.035 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Research Letter Wan, Marilyn T. Shin, Daniel B. Winthrop, Kevin L. Gelfand, Joel M. The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic |
| title | The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic |
| title_full | The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic |
| title_fullStr | The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic |
| title_full_unstemmed | The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic |
| title_short | The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic |
| title_sort | risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: a meta-estimate of pivotal trials relevant to decision making during the covid-19 pandemic |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235584/ https://www.ncbi.nlm.nih.gov/pubmed/32416207 http://dx.doi.org/10.1016/j.jaad.2020.05.035 |
| work_keys_str_mv | AT wanmarilynt theriskofrespiratorytractinfectionsandsymptomsinpsoriasispatientstreatedwithinterleukin17pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT shindanielb theriskofrespiratorytractinfectionsandsymptomsinpsoriasispatientstreatedwithinterleukin17pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT winthropkevinl theriskofrespiratorytractinfectionsandsymptomsinpsoriasispatientstreatedwithinterleukin17pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT gelfandjoelm theriskofrespiratorytractinfectionsandsymptomsinpsoriasispatientstreatedwithinterleukin17pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT wanmarilynt riskofrespiratorytractinfectionsandsymptomsinpsoriasispatientstreatedwithinterleukin17pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT shindanielb riskofrespiratorytractinfectionsandsymptomsinpsoriasispatientstreatedwithinterleukin17pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT winthropkevinl riskofrespiratorytractinfectionsandsymptomsinpsoriasispatientstreatedwithinterleukin17pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic AT gelfandjoelm riskofrespiratorytractinfectionsandsymptomsinpsoriasispatientstreatedwithinterleukin17pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic |